| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
7,215 |
6,920 |
$1.19M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,026 |
4,837 |
$1.17M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,535 |
1,468 |
$501K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
434 |
425 |
$196K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
291 |
290 |
$168K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
924 |
906 |
$85K |
| 70450 |
Computed tomography, head or brain; without contrast material |
275 |
273 |
$54K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
61 |
61 |
$14K |
| 10060 |
|
41 |
39 |
$9K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
13 |
13 |
$6K |
| 72131 |
|
16 |
16 |
$5K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
57 |
54 |
$2K |
| 70486 |
|
13 |
13 |
$1K |
| 71250 |
|
40 |
40 |
$809.01 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
873 |
791 |
$553.96 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,827 |
1,743 |
$99.64 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,211 |
1,096 |
$82.46 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,388 |
1,277 |
$63.87 |
| 80053 |
Comprehensive metabolic panel |
2,547 |
2,406 |
$35.27 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,629 |
2,513 |
$13.74 |
| 81025 |
|
1,535 |
1,500 |
$13.32 |
| J3490 |
Unclassified drugs |
534 |
490 |
$10.39 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,170 |
1,096 |
$9.12 |
| 82550 |
|
599 |
584 |
$8.82 |
| 80076 |
|
401 |
388 |
$7.35 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,499 |
1,395 |
$7.15 |
| 80051 |
|
599 |
584 |
$6.31 |
| 81003 |
|
3,152 |
3,033 |
$5.93 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
139 |
127 |
$5.26 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
215 |
208 |
$4.91 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
206 |
192 |
$4.46 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
347 |
347 |
$0.17 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
196 |
194 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,856 |
1,794 |
$0.00 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
168 |
125 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
410 |
374 |
$0.00 |
| 82803 |
|
222 |
210 |
$0.00 |
| 76801 |
|
103 |
101 |
$0.00 |
| 83605 |
|
238 |
210 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
265 |
261 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
53 |
52 |
$0.00 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,501 |
1,413 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
599 |
589 |
$0.00 |
| 84484 |
|
370 |
356 |
$0.00 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
42 |
42 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
136 |
136 |
$0.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
46 |
45 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
2,146 |
2,060 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
109 |
109 |
$0.00 |
| 84703 |
|
612 |
574 |
$0.00 |
| 82150 |
|
45 |
41 |
$0.00 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
155 |
151 |
$0.00 |
| 71045 |
Radiologic examination, chest; single view |
528 |
517 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
181 |
176 |
$0.00 |
| 85379 |
|
102 |
101 |
$0.00 |
| 93971 |
|
42 |
42 |
$0.00 |
| 87428 |
|
84 |
84 |
$0.00 |
| 82962 |
|
74 |
64 |
$0.00 |
| 12001 |
|
40 |
40 |
$0.00 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
15 |
14 |
$0.00 |
| 83880 |
|
126 |
125 |
$0.00 |
| 96376 |
|
32 |
32 |
$0.00 |
| 87480 |
|
32 |
32 |
$0.00 |
| 87510 |
|
32 |
32 |
$0.00 |
| 87077 |
|
50 |
50 |
$0.00 |
| 76830 |
Ultrasound, transvaginal |
12 |
12 |
$0.00 |
| A9270 |
Non-covered item or service |
39 |
34 |
$0.00 |
| 82947 |
|
527 |
515 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
196 |
194 |
$0.00 |
| 87634 |
|
124 |
124 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
546 |
528 |
$0.00 |
| 71046 |
Radiologic examination, chest; 2 views |
1,066 |
1,029 |
$0.00 |
| 87631 |
|
1,045 |
1,033 |
$0.00 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
616 |
598 |
$0.00 |
| 87420 |
|
13 |
13 |
$0.00 |
| 80306 |
|
265 |
253 |
$0.00 |
| 82565 |
|
538 |
519 |
$0.00 |
| 73130 |
|
159 |
156 |
$0.00 |
| 74018 |
|
116 |
116 |
$0.00 |
| 73110 |
|
59 |
57 |
$0.00 |
| 90715 |
|
109 |
109 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
114 |
114 |
$0.00 |
| 81513 |
|
41 |
40 |
$0.00 |
| 93976 |
|
61 |
60 |
$0.00 |
| 73080 |
|
46 |
45 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
85 |
83 |
$0.00 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
55 |
54 |
$0.00 |
| 73562 |
|
127 |
121 |
$0.00 |
| 84520 |
|
537 |
519 |
$0.00 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
43 |
43 |
$0.00 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
74 |
74 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
105 |
102 |
$0.00 |
| 73630 |
|
168 |
165 |
$0.00 |
| 73610 |
|
123 |
122 |
$0.00 |
| 73030 |
|
56 |
56 |
$0.00 |
| 87186 |
|
35 |
35 |
$0.00 |
| 87660 |
|
32 |
32 |
$0.00 |
| 85610 |
|
13 |
12 |
$0.00 |
| 87481 |
|
41 |
40 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
14 |
14 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
12 |
12 |
$0.00 |
| 84702 |
|
65 |
64 |
$0.00 |
| 72100 |
|
15 |
15 |
$0.00 |